# A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine

> **NCT06546475** · PHASE4 · NOT_YET_RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Psychosis

## Interventions

- **DRUG:** N-Acetylcysteine

## Key facts

- **NCT ID:** NCT06546475
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06546475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06546475, "A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06546475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*